Visceral Fat Thickness, Serum Adiponectin, and Metabolic Syndrome in Patients with Colorectal Adenomas
Authors:
- Dimitrije DamjanovDimitrije Damjanov
- Tijana IčinTITijana Ičin
- Željka SavićŽSŽeljka Savić
- Nebojša JanjićNJNebojša Janjić
- Stanislava NikolićSNStanislava Nikolić
- Olgica Latinović BošnjakOBOlgica Latinović Bošnjak
- Žarko KrnetićŽKŽarko Krnetić
- Vladimir VračarićVVVladimir Vračarić
- Božidar DejanovićBDBožidar Dejanović
- Nadica KovačevićNKNadica Kovačević
Open Access
- 22 September 2024
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (9) , 1008
Abstract
Background/Objectives: Most cases of colorectal cancer (CRC) arise from adenomatous polyps. Identifying risk factors for colorectal adenoma (CRA) is critical for CRC prevention. Emerging evidence suggests a link between metabolic syndrome (MetS) and an elevated risk of CRA and CRC, potentially mediated by visceral obesity and adiponectin (APN). We aimed to evaluate the association between different markers of visceral obesity, serum APN, MetS, and the presence of CRA. Methods: A cross-sectional study was conducted at the University Clinical Center of Vojvodina, involving 120 patients, aged 40–75 years, who underwent colonoscopy between January 2022 and January 2023. Sixty patients with CRA were compared to 60 controls with normal colonoscopy findings. Visceral fat thickness (VFT) was measured using ultrasound (US), and bioelectrical impedance analysis (BIA) was used to assess visceral fat area (VFA). Serum APN levels, anthropometric measures, and MetS components were also evaluated. Results: Patients with CRA had significantly higher VFT measured by US (p < 0.05), but no significant differences were found in VFA measured by BIA, waist circumference (WC), or waist-to-hip ratio (WHR). MetS was significantly more prevalent in the CRA group (55% vs. 31.6%, p < 0.05), and logistic regression confirmed MetS as a significant predictor of CRA presence (OR = 2.6). Serum APN levels were inversely correlated with visceral fat measurements and MetS (p < 0.01), but no significant difference in APN levels was observed between patients with and without CRA. Conclusions: This study highlights the importance of VFT measured by US and the presence of MetS as significant factors associated with CRA.Keywords
This publication has 28 references indexed in Scilit:
- Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart?Gastroenterology, 2023
- Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysisClinics and Research in Hepatology and Gastroenterology, 2021
- Colorectal cancerThe Lancet, 2019
- Global burden of colorectal cancer: emerging trends, risk factors and prevention strategiesNature Reviews Gastroenterology & Hepatology, 2019
- Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studiesAnnals of Oncology, 2014
- Adiposity distribution influences circulating adiponectin levelsTranslational Research, 2014
- Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenomaInternational Journal of Cancer, 2014
- Association of colorectal adenoma with components of metabolic syndromeCancer Causes & Control, 2012
- Accuracy, Reproducibility and Repeatability of Ultrasonography in the Assessment of Abdominal AdiposityAcademic Radiology, 2011
- Association of Metabolic Syndrome With Proximal and Synchronous Colorectal NeoplasmClinical Gastroenterology and Hepatology, 2007